참고문헌
- Arnt J. Pharmacological specificity of conditioned avoidance response inhibition in rats. Inhibition by neuroleptics and correlation to dopamine receptor blockade. Acta Pharmacol Toxicol 51: 321−329, 1982 https://doi.org/10.1111/j.1600-0773.1982.tb01032.x
- Bartoszyk GD, Amsterdam C van, Böttcher H, Seyfried CA. EMD 281014, a new selective serotonin 5-HT2A receptor antagonist. Eur J Pharmacol 473: 229−230, 2003 https://doi.org/10.1016/S0014-2999(03)01992-7
- Carlsson A, Lindqvist M. Effect of chlorpromazine or haloperidol on the formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol (Kbh.) 20: 140−144, 1963
- Cook L, Morris RW, Mattis PA. Neuropharmacological and behavioral effects of chlorpromazine (thorazine hydrochloride). J Pharmacol Exp Ther 113: 11−12, 1955
- Costentin J, Protais P, Schwartz JC. Rapid and dissociated changes in sensitivities of different dopamine receptors in mouse brain. Nature 257: 405−407, 1975 https://doi.org/10.1038/257405a0
- Darmani NA, Martin BR, Pandey U, Glennon RA. Do functional relationships exist between 5-HT1A and 5-HT2 receptors? Pharmacol Biochem Behav 36: 901−906, 1990 https://doi.org/10.1016/0091-3057(90)90098-3
- Davidson AB, Weidley E. Differential effects of neuroleptic and other psychotropic agents on acquisition of avoidance in rats. Life Sci 18: 1279−1284, 1976 https://doi.org/10.1016/0024-3205(76)90205-8
- Dunham NW, Miya TS. A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc 46: 208−209, 1957
- Egashira N, Mishima K, Uchida T, Hasebe N, Nagai H, Mizuki A, Iwasaki K, Ishii H, Nishimura RJ, Shoyama Y, Fujiwara M. Anandamide inhibits the DOI-induced head-twitch response in mice. Psychopharmacology 171: 382−389, 2004 https://doi.org/10.1007/s00213-003-1611-y
- Gustafsson B, Christensson E. Amperozide, a new putative antipsychotic drug with a limbic mode of action on dopamine mediated behavior. Pharmacol Toxicol 66 Suppl 1: 12−17, 1990 https://doi.org/10.1111/j.1600-0773.1990.tb01600.x
- Kroeze WK, Hufeisen SJ, Popadak BA, Renock SM, Steinberg S, Ernsberger P, Jayathilake K, Meltzer HY, Roth BL. H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology 28: 519−526, 2003 https://doi.org/10.1038/sj.npp.1300027
- Janssen PAJ, Niemegeers CJE, Smellekens KHL. Is it possible to predict the clinical effects of neuroleptic drugs (major tranquilizers) from animal data? Drug Res 15: 56−69, 1965
- Jones BJ, Blackburn TP. The medical benefit of 5-HT research. Pharmacol Biochem Behav 71: 555−568, 2002 https://doi.org/10.1016/S0091-3057(01)00745-6
- Matthysse S. Antipsychotic drug actions: a clue to the pathology of schizophrenia? Fed Proc 32: 200−205, 1973
- Meltzer HY, Li Z, Kaneda Y, Ichikawa J. Serotonin receptors: their key role in drugs to treat schizophrenia. Progr Neuro Psychopharmacol Biol Psychiatr 27: 1159−1172, 2003 https://doi.org/10.1016/j.pnpbp.2003.09.010
- Moore NA, Tye NC, Axton MS, Risius FC. The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent. J Pharmacol Exp Ther 262: 545−551, 1992
- Moore S, Kenyon P. Atypical antipsychotics, clozapine and sulpiride do not antagonize amphetamine-induced stereotyped locomotion. Psychopharmacology 114: 123−130, 1994 https://doi.org/10.1007/BF02245453
- Ogren SO, Hall H, Kohler C, Magnusson O, Lindbom LO, Angeby K, Florvall L. Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain. Eur J Pharmacol 102: 459−474, 1984 https://doi.org/10.1016/0014-2999(84)90567-3
-
Park WK, Jeong DY, Yun CW, Lee SH, Cho HY, Kim GD, Koh HY, Pae AN, Cho YS, Choi KI, Jung JY, Jung SH, Kong JY. Pharmacological actions of a novel and selective dopamine
$D_3$ receptor antagonist, KCH-1110. Pharm Research 48: 615−622, 2003 https://doi.org/10.1016/S1043-6618(03)00242-1 - Peroutka SJ, Snyder SH. Relationship of neuroleptic drug effects at brain dopamine, serotonin, a-adrenergic, and histamine receptors to clinical potency. Am J Psychiatry 137: 1518−1522, 1980 https://doi.org/10.1176/ajp.137.12.1518
- Protais P, Constentin J, Schwartz JC. Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum. Psychopharmacology 50: 1−6, 1976 https://doi.org/10.1007/BF00634146
- Protais P, Costentin J, Schwartz JC. Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum. Psychopharmacology (Berlin) 50: 1−6, 1976 https://doi.org/10.1007/BF00634146
-
Reavill C, Kettle A, Holland V, Riley G, Blackburn TP. Attenuation of haloperidol-induced catalepsy by a
$5-HT_{2C}$ receptor antagonist. Br J Pharmacol 126: 572−574, 1999 https://doi.org/10.1038/sj.bjp.0702350 - Schreiber R, Brocco M, Audinot V, Gobert A, Veiga S, Millan MJ. (1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane)-induced head- twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors : modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists. J Pharmacol Exp Ther 273: 101−112, 1995
- Seeman P, Van Tol HH. Dopamine receptor pharmacology. Trends Pharmacol Sci 15: 264−270, 1994 https://doi.org/10.1016/0165-6147(94)90323-9
- Sibley DR, Monsma Jr FJ, Shen Y. Molecular neurobiology of dopaminergic receptors. Int Rev Neurobiol 35: 391−415, 1993 https://doi.org/10.1016/S0074-7742(08)60573-5
- Snyder SH, Banergee SP, Yamamura HI, Greenberg D. Drugs, neurotransmitters and schizophrenia. Science 184: 1243−1245, 1974 https://doi.org/10.1126/science.184.4143.1243
- Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC. Molecular cloning and characterization of a novel dopamine receptor D3 as a target for neuroleptics. Nature 347: 146−151, 1990 https://doi.org/10.1038/347146a0
- Sokoloff P, Schwartz JC. Novel dopamine receptors half a decade later. Trends Pharmacol Sci 16: 270−275, 1995 https://doi.org/10.1016/S0165-6147(00)89044-6
- Stahl SM. Psychopharmacology of antidepressants. 1st ed. Martin Dunitz Ltd, London, p 31-38, 1997
- Van Rossum JM. The significance of dopamine-receptor blockade for the action of neuroleptic drugs. Arch Int Pharmacodyn Ther 160: 492−494, 1966
- Wadenberg ML, Hicks PB. The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics? Neurosci Biohav Rev 23: 851−862, 1999 https://doi.org/10.1016/S0149-7634(99)00037-8
- Wadenberg ML, Kapur S, Soliman A, Jones C. Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats. Psychopharmacology 150: 422−429, 2000 https://doi.org/10.1007/s002130000466
- Willins DL, Meltzer HY. Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats. J Pharmacol Exp Ther 282: 699−706, 1997
- Yoon BS, Park EH, Park EH, Kwon JT, Hong SB, Dong SM, Kim YH, Heo J, Ji MK, Kim YG, Kwak BS, Choi JS, Kim HT. Effects of a new antipsychotic drug (YKP1447) on impaired prepulse inhibition induced by apomorphine and phencyclidine in rats. Korean J Psychopharmacol 19: 38−45, 2008
- Aisa B, Tordera R, Lasheras B, Del Rio J, Ramirez MJ. Effects of maternal separation on hypothalamic-pituitary-adrenal responses, cognition and vulnerability to stress in adult female rats. Neuroscience 154: 1218−1226, 2008 https://doi.org/10.1016/j.neuroscience.2008.05.011